Evidence supporting the use of: Vitamine E (mixed tocotrienols)
For the body system: Prostate

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, specifically in the form of mixed tocotrienols, has been investigated for its potential role in supporting prostate health, particularly in the context of prostate cancer prevention. Some scientific studies have observed that tocotrienols may possess antioxidant and anti-inflammatory properties that could theoretically protect prostate cells from damage and reduce cancer risk. Preclinical (lab and animal) studies suggest tocotrienols can inhibit prostate cancer cell growth and induce apoptosis (programmed cell death) in cancerous cells. However, large human clinical trials are limited, and the results have been inconsistent. Notably, studies using the more common form of vitamin E (alpha-tocopherol) have not demonstrated significant benefits for prostate health and may even suggest harm at high doses. Tocotrienols are less well studied, but current clinical evidence does not robustly support their use for prostate health or disease prevention. Therefore, while there is some scientific rationale and early-stage evidence, the rating remains low due to insufficient high-quality human data. Tocotrienols are not a standard or widely recommended supplement for prostate support based on current scientific consensus.

More about Vitamine E (mixed tocotrienols)
More about Prostate

Products containing Vitamine E (mixed tocotrienols)

We currently have no products on Vitabase that contain this ingredient.